These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1786063)

  • 21. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 22. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
    S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
    Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
    Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J
    Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of a cyclosporin-ketoconazole combination: making renal transplantation affordable in developing countries.
    Gerntholtz T; Pascoe MD; Botha JF; Halkett J; Kahn D
    Eur J Clin Pharmacol; 2004 May; 60(3):143-8. PubMed ID: 15083250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation.
    Morris PJ; Chapman JR; Allen RD; Ting A; Thompson JF; Dunnill MS; Wood RF
    Lancet; 1987 Mar; 1(8533):586-91. PubMed ID: 2881131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
    Qazi YA; Forrest A; Tornatore K; Venuto RC
    Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
    Wahlberg J; Hanås E; Bergström C; Fellström B; Skarp-Orberg I; Frödin L
    Transplant Proc; 1992 Feb; 24(1):311-2. PubMed ID: 1539291
    [No Abstract]   [Full Text] [Related]  

  • 29. Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study.
    Sweny P; Lui SF; Scoble JE; Varghese Z; Fernando ON; Moorhead JF
    Transpl Int; 1990 May; 3(1):19-22. PubMed ID: 2196060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion from cyclosporine to azathioprine in renal allograft recipients.
    Rocher LL; Milford EL; Kirkman RL; Carpenter CB; Strom TB; Tilney NL
    Transplantation; 1984 Dec; 38(6):669-74. PubMed ID: 6390830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
    Hilbrands LB; Hoitsma AJ; Koene KA
    Transplantation; 1996 Apr; 61(7):1038-46. PubMed ID: 8623182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
    Thomas DW; Baboolal K; Subramanian N; Newcombe RG
    J Clin Periodontol; 2001 Jul; 28(7):706-9. PubMed ID: 11422595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.
    Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O
    N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A in children with persistent renal transplant rejection and progressively deteriorating graft function.
    Geary DF; Thorner P; Baumal R; Major M; Arbus G
    Pediatr Nephrol; 1987 Apr; 1(2):140-4. PubMed ID: 3153270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation.
    Sandrini S; Maiorca R; Scolari F; Cancarini G; Setti G; Gaggia P; Cristinelli L; Zubani R; Bonardelli S; Maffeis R; Portolani N; Nodari F; Giulini SM
    Transplantation; 2000 May; 69(9):1861-7. PubMed ID: 10830223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of conversion from conventional immunosuppressive therapy to cyclosporin A in complications following kidney transplantation].
    Scholz D; Blank W; Bärwolf C; Ditscherlein G; Christenfeld R; Hüller H
    Z Urol Nephrol; 1990 Feb; 83(2):69-76. PubMed ID: 2368516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporin A-induced transient rise in plasma alkaline phosphatase in kidney transplant patients.
    Briner VA; Landmann J; Brunner FP; Thiel G
    Transpl Int; 1993 Mar; 6(2):99-107. PubMed ID: 8447931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine.
    Machado PG; Felipe CR; Park SI; Garcia R; Moreira S; Casarini D; Franco M; Alfieri F; Tedesco-Silva H; Medina-Pestana JO
    Braz J Med Biol Res; 2004 Sep; 37(9):1303-12. PubMed ID: 15334195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Forearm vasorelaxation in hypertensive renal transplant patients: the impact of withdrawal of cyclosporine.
    van den Dorpel MA; van den Meiracker AH; Lameris TW; Weimar W; Man in't Veld AJ
    J Hypertens; 1998 Mar; 16(3):331-7. PubMed ID: 9557926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.